Antibiotic effectiveness study in infection patients
Part of Infections clinical trials.
This study looks at how well beta-lactam antibiotics (a common type of antibiotic) work in people being treated for infections at Imperial College NHS Trust. The information may help doctors make better dosing decisions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You are being treated for an infection at Imperial College NHS Trust.
- You have received a beta-lactam antibiotic (like penicillin or amoxicillin) in the last 2 days, or are about to start one.
- If you can't give consent, you have delirium from infection, a brain infection, or are critically ill on a breathing machine.
- You do not have severe anemia, a bleeding disorder, or a terminal illness under palliative care.
- You are not in another trial that blocks this one, and you are not in prison or under legal protection.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether giving common antibiotics in certain dose schedules (either through a drip over time or continuously) is done in a way that fits pediatric intensive care needs. It may help improve antibiotic treatment for children who are very sick and need antibiotics.
This trial tests whether giving a certain type of antibiotic (beta-lactam) continuously or intermittently works better for patients in the intensive care unit with pneumonia or a urinary tract infection and signs of sepsis. Sepsis is a serious response to an infection, so better antibiotic delivery could improve outcomes.
This study monitors how antibiotics behave in the body for ICU patients being treated for sepsis or septic shock. It aims to learn whether better monitoring can support safer, more effective antibiotic use.
This study tests a careful antibiotic-use program for patients with a bloodstream infection caused by a group of bacteria called Enterobacterales. The goal is to use the right antibiotics for the right amount of time. It may help you get better treatment with fewer side effects.
This study measures levels of beta-lactam antibiotics in the blood of ICU patients with sepsis to ensure the right dose is given. It aims to improve treatment by checking if antibiotic levels are effective without being too high or too low.
This trial tests a new device that measures antibiotic levels in blood quickly at the bedside, so doctors can adjust your dose to make sure it's effective. It may help ICU patients on beta-lactam antibiotics get the right amount.
Hear when a new Drug Monitoring trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.